Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2022 Revenue Results

Author's Avatar
Jan 10, 2023

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today reported preliminary revenue results for the fourth quarter and full year ended December 31, 2022.